{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:47:48Z","timestamp":1787014068146,"version":"build-2736575974"},"reference-count":29,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Unregulated anabolic\u2013androgenic steroid (AAS) markets are a global phenomenon with significant variability in product composition and purity. This study aimed to determine the chemical composition of AAS sold in Australia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study analysed anonymously donated AAS samples. Samples were chemically analysed by an independent forensic laboratory using gas chromatography\u2013mass spectrometry, liquid chromatography\u2013mass spectrometry and inductively coupled plasma analysis to identify active ingredients, contaminants and heavy metals, with results interpreted in the context of harm reduction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Analysis of 28 AAS samples (16 injectable, 10 oral, 2 raw powders) revealed that 15 samples were mislabelled or mis\u2010sold. When considering the 21 samples with clearly defined expected labelled dosages, 4 of these were within a \u00b15% deviation of the expected purity. Twelve heavy metals were detected in injectable and oral products, with mean concentrations ranging from 0.07 to 62.54\u2009\u03bcg\/mL in injectables and 1.94\u201347,901\u2009\u03bcg\/g in orals. Seven metals were identified in raw powders (mean 23.0\u2009\u03bcg\/g, range 0.96\u201351.73\u2009\u03bcg\/g).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion and Conclusions<\/jats:title>\n                    <jats:p>The variability and contamination of AAS products pose significant health risks. Implementing a comprehensive surveillance and testing system is essential. This approach would track trends, identify contaminants and provide consumers with real\u2010time, accurate information to support informed decision\u2010making and harm reduction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dar.70007","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T17:00:35Z","timestamp":1753117235000},"page":"1641-1647","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lead Astray? The Hidden Contaminants in Australian Anabolic\u2013Androgenic Steroid Market and Their Potential Health Impact"],"prefix":"10.1111","volume":"44","author":[{"given":"Alison","family":"Craven","sequence":"first","affiliation":[{"name":"PEDTest Australia  Perth Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7474-0173","authenticated-orcid":false,"given":"Jason","family":"Ferris","sequence":"additional","affiliation":[{"name":"Centre for Health Services Research, The University of Queensland  Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-1055","authenticated-orcid":false,"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Monash Addiction Research Centre, Eastern Health Clinical School, Monash University  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6177-0266","authenticated-orcid":false,"given":"Timothy","family":"Piatkowski","sequence":"additional","affiliation":[{"name":"Centre for Health Services Research, The University of Queensland  Brisbane Australia"},{"name":"School of Applied Psychology and Griffith Centre for Mental Health, Griffith University  Australia"},{"name":"Queensland Injectors Voice for Advocacy and Action  Sunshine Coast Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13734-4"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.peh.2015.10.004"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104139"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13931"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2016.11.005"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/14659891.2014.911977"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/09687637.2022.2132135"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15734"},{"key":"e_1_2_10_10_1","volume-title":"ICH Guideline Q3D (R2) on Elemental Impurities","author":"European Medicines Agency","year":"2025"},{"key":"e_1_2_10_11_1","unstructured":"Australian Government Department of Health Disability and Aging \u201cGuidance for TGO 101 Standard for Tablets Capsules and Pills \u201d2025 https:\/\/www.tga.gov.au\/sites\/default\/files\/2025\u201005\/complying\u2010with\u2010quality\u2010standards\u2010for\u2010tablets\u2010capsules\u2010and\u2010pills.pdf."},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.16643"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000403"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.70009"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-020-02335-0"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.14015"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2017.03.016"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2021.110771"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2024.127481"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76000-w"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464170-00002"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.9785"},{"issue":"9","key":"e_1_2_10_23_1","first-page":"1068","article-title":"Environmental Lead Exposure: A Public Health Problem of Global Dimensions","volume":"78","author":"Tong S.","year":"2000","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-010-9343-z"},{"key":"e_1_2_10_25_1","first-page":"1","article-title":"Health Effects of Cadmium Exposure\u2014A Review of the Literature and a Risk Estimate","volume":"24","author":"J\u00e4rup L.","year":"1998","journal-title":"Scandinavian Journal of Work, Environment & Health"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.3961\/jpmph.14.035"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.165"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.9.2.60"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-4179(98)00159-4"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.15187"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.70007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T07:08:36Z","timestamp":1756883316000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.70007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1111\/dar.70007"],"URL":"https:\/\/doi.org\/10.1111\/dar.70007","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"2025-02-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}